Cheng P Y, Morgan E T
Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Curr Drug Metab. 2001 Jun;2(2):165-83. doi: 10.2174/1389200013338676.
Hepatic cytochrome P450 (P450) enzyme activities and gene expression can be profoundly altered in disease states. In general the levels of affected hepatic P450 enzymes are depressed by diseases, causing potential and documented impairment of drug clearance and clinical drug toxicity. However, modulation of P450s is enzyme selective and this selectivity differs among different diseases. This review will concentrate on regulation of P450s in diabetes, obesity and infectious and inflammatory disease, conditions that affect millions of people worldwide every day.
肝脏细胞色素P450(P450)酶活性和基因表达在疾病状态下会发生深刻改变。一般来说,受影响的肝脏P450酶水平会因疾病而降低,从而导致药物清除率潜在的以及已被证实的受损和临床药物毒性。然而,P450的调节具有酶选择性,且这种选择性在不同疾病中有所不同。本综述将聚焦于糖尿病、肥胖症以及感染性和炎症性疾病中P450的调节,这些疾病每天影响着全球数百万人。